Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthijs D Kruizinga

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Handbook of Experimental Pharmacology|November 11, 2019
The Future of Clinical Trial Design: The Transition from Hard Endpoints to Value-Based EndpointsMatthijs D Kruizinga, Frederik E Stuurman, Geert J Groeneveld, et al.
British Journal of Clinical Pharmacology|March 24, 2026
Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practiceMees H P Stoop, Gertjan J A Driessen, Adam F Cohen, et al.
Pediatric Blood & Cancer|January 12, 2017
The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patientsMatthijs D Kruizinga, Dorine Bresters, Frans J Smiers, et al.
Journal of Crohn'S & Colitis|October 12, 2023
Validation of the Pharmacokinetic Model for Anti-TNFα Clearance in Infants Exposed to Anti-TNFα During PregnancyJantien W Wieringa, Matthijs D Kruizinga, Gertjan J A Driessen, et al.
Clinical Pharmacokinetics|March 27, 2023
Optimization of β-Lactam Dosing Regimens in Neonatal Infections: Continuous and Extended Administration versus Intermittent AdministrationEmiel Leegwater, Leo Wewerinke, Anne M de Grauw, et al.
Therapeutic Drug Monitoring|July 12, 2021
Theoretical Performance of Nonlinear Mixed-Effect Models Incorporating Saliva as an Alternative Sampling Matrix for Therapeutic Drug Monitoring in Pediatrics: A Simulation StudyMatthijs D Kruizinga, Frederik E Stuurman, Gertjan J A Driessen, et al.
Respiration; International Review of Thoracic Diseases|May 18, 2021
Postdischarge Recovery after Acute Pediatric Lung Disease Can Be Quantified with Digital BiomarkersMatthijs D Kruizinga, Allison Moll, Ahnjili Zhuparris, et al.
Frontiers in Pediatrics|April 30, 2021
Development and Technical Validation of a Smartphone-Based Cry Detection AlgorithmAhnjili ZhuParris, Matthijs D Kruizinga, Max van Gent, et al.
British Journal of Clinical Pharmacology|November 23, 2021
Population pharmacokinetics of clonazepam in saliva and plasma: Steps towards noninvasive pharmacokinetic studies in vulnerable populationsMatthijs D Kruizinga, Rob G J A Zuiker, Kirsten R Bergmann, et al.
Journal of Clinical Medicine|November 27, 2021
Effect of INTELLiVENT-ASV versus Conventional Ventilation on Ventilation Intensity in Patients with COVID-19 ARDS-An Observational StudyLaura A Buiteman-Kruizinga, Hassan E Mkadmi, Ary Serpa Neto, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Handbook of Experimental Pharmacology|November 11, 2019
The Future of Clinical Trial Design: The Transition from Hard Endpoints to Value-Based EndpointsMatthijs D Kruizinga, Frederik E Stuurman, Geert J Groeneveld, et al.
British Journal of Clinical Pharmacology|March 24, 2026
Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practiceMees H P Stoop, Gertjan J A Driessen, Adam F Cohen, et al.
Pediatric Blood & Cancer|January 12, 2017
The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patientsMatthijs D Kruizinga, Dorine Bresters, Frans J Smiers, et al.
Journal of Crohn'S & Colitis|October 12, 2023
Validation of the Pharmacokinetic Model for Anti-TNFα Clearance in Infants Exposed to Anti-TNFα During PregnancyJantien W Wieringa, Matthijs D Kruizinga, Gertjan J A Driessen, et al.
Clinical Pharmacokinetics|March 27, 2023
Optimization of β-Lactam Dosing Regimens in Neonatal Infections: Continuous and Extended Administration versus Intermittent AdministrationEmiel Leegwater, Leo Wewerinke, Anne M de Grauw, et al.
Therapeutic Drug Monitoring|July 12, 2021
Theoretical Performance of Nonlinear Mixed-Effect Models Incorporating Saliva as an Alternative Sampling Matrix for Therapeutic Drug Monitoring in Pediatrics: A Simulation StudyMatthijs D Kruizinga, Frederik E Stuurman, Gertjan J A Driessen, et al.
Respiration; International Review of Thoracic Diseases|May 18, 2021
Postdischarge Recovery after Acute Pediatric Lung Disease Can Be Quantified with Digital BiomarkersMatthijs D Kruizinga, Allison Moll, Ahnjili Zhuparris, et al.
Frontiers in Pediatrics|April 30, 2021
Development and Technical Validation of a Smartphone-Based Cry Detection AlgorithmAhnjili ZhuParris, Matthijs D Kruizinga, Max van Gent, et al.
British Journal of Clinical Pharmacology|November 23, 2021
Population pharmacokinetics of clonazepam in saliva and plasma: Steps towards noninvasive pharmacokinetic studies in vulnerable populationsMatthijs D Kruizinga, Rob G J A Zuiker, Kirsten R Bergmann, et al.
Journal of Clinical Medicine|November 27, 2021
Effect of INTELLiVENT-ASV versus Conventional Ventilation on Ventilation Intensity in Patients with COVID-19 ARDS-An Observational StudyLaura A Buiteman-Kruizinga, Hassan E Mkadmi, Ary Serpa Neto, et al.
Pageof 3